Emergency department evaluation of patients with fever and chemotherapy-induced neutropenia

被引:31
作者
Perrone, J [1 ]
Hollander, JE [1 ]
Datner, EM [1 ]
机构
[1] Univ Penn, Dept Emergency Med, Div Toxicol, Philadelphia, PA USA
关键词
neutropenia; fever; granulocytopenia; chemotherapy; bacteremia;
D O I
10.1016/j.jemermed.2004.03.004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We sought to describe the common causes of infection in patients presenting to the Emergency Department (ED) with elevated temperature and chemotherapy-induced neutropenia and to determine the frequency with which the ED diagnosis of infection is consistent with the final hospital discharge diagnosis. We performed a structured restrospective chart review of ED patients with fever (T > 38degreesC) and neutropenia (absolute neutrophil count < 1000/mm(3)) over a 2-year period. Fifty-five episodes of neutropenic fever occurred in 52 patients (mean age 52 years, range 18-86 years; 53% men). Twenty-six patients (47%) were found to have a specific infection identified. Of these, 21/26 (81%; 95 % CI, 70-91%) had the source of infection identified while in the ED. All patients who had a focal site of infection identified during their hospitalization were diagnosed in the ED (100%; 95% CI, 86-100%). The other 5 patients, without a source identified in the ED, were found to have bacteremia. The 29 patients without a source identified in the ED were hospitalized and had negative blood and urine cultures and were discharged to home after resolution of fever. A thorough history, physical examination, chest radiograph and urinalysis in the ED identified all patients with a focus of infection. Meticulous ED evaluation of patients with neutropenia and fever may be sufficient to diagnose most sources of infection; however, a significant number of patients without an identifiable focus may have bacteremia. (C) 2004 Elsevier Inc.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 18 条
[1]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[2]  
*ASS COMM CANC CTR, 2003, COMM CANC PROGR US
[3]   Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial [J].
Borras, JM ;
Sanchez-Hernandez, A ;
Navarro, M ;
Martinez, M ;
Mendez, E ;
Ponton, JLL ;
Espinas, JA ;
Germa, JR .
BRITISH MEDICAL JOURNAL, 2001, 322 (7290) :826-828A
[4]   REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER [J].
CRAWFORD, J ;
OZER, H ;
STOLLER, R ;
JOHNSON, D ;
LYMAN, G ;
TABBARA, I ;
KRIS, M ;
GROUS, J ;
PICOZZI, V ;
RAUSCH, G ;
SMITH, R ;
GRADISHAR, W ;
YAHANDA, A ;
VINCENT, M ;
STEWART, M ;
GLASPY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :164-170
[5]   A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy [J].
Freifeld, A ;
Marchigiani, D ;
Walsh, T ;
Chanock, S ;
Lewis, L ;
Hiemenz, J ;
Hiemenz, S ;
Hicks, JE ;
Gill, V ;
Steinberg, SM ;
Pizzo, PP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :305-311
[6]   EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA AND ASSOCIATED MORBIDITY DUE TO CHEMOTHERAPY FOR TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
SCHER, H ;
STERNBERG, C ;
WONG, G ;
GROUS, J ;
YAGODA, A ;
FAIN, K ;
MOORE, MAS ;
CLARKSON, B ;
OETTGEN, HF ;
ALTON, K ;
WELTE, K ;
SOUZA, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22) :1414-1422
[7]   1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Brown, AE ;
Edwards, JE ;
Feld, R ;
Pizzo, P ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :551-573
[8]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[9]   Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy [J].
Kern, WV ;
Cometta, A ;
de Rock, R ;
Langenaeken, J ;
Paesmans, M ;
Gaya, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :312-318
[10]   The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients [J].
Klastersky, J ;
Paesmans, M ;
Rubenstein, EB ;
Boyer, M ;
Elting, L ;
Feld, R ;
Gallagher, J ;
Herrstedt, J ;
Rapoport, B ;
Rolston, K ;
Talcott, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :3038-3051